IRCT20201024049130N1招募中3 期
Evaluation of the efficacy of Silymarin nanomicelles in hospitalized patients with COVID-19
Artesh University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients with clinical or laboratory diagnosis of covid-19 should be hospitalized based on the opinion of a specialist physician.
- •age between 18 to 75
- •Signing an informed consent form
排除标准
- •Pregnancy and lactation
- •Active liver disease
- •Severe renal failure GFR <30 ml/min
- •Inability of the patient to swallow oral medication
研究者
相似试验
招募中
3 期
Protective effect of oral nano-silymarin on vancomycin-induced nephrotoxicity????????????? ???????????.IRCT20200408046990N9Mashhad University of Medical Sciences60
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60